We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RPAY:NASDAQRepay Holdings Corporation Analysis

Data as of 2026-06-09 - not real-time

$3.45

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Repay Holdings trades around $3.45, well below its DCF‑derived fair value of $4.16, implying roughly a 71% upside potential. The stock benefits from an attractive forward P/E of 3.2 and a solid gross margin of 75%, but it is hampered by a near‑zero operating margin and a steep net loss (-82.7% profit margin). Cash generation looks modest with $44.7 M in cash versus $401 M in debt, yielding a high debt‑to‑equity ratio that adds balance‑sheet risk. Recent corporate actions—most notably the board’s rejection of a 75% premium cash offer from activist Forager Capital and the integration of the KUBRA acquisition—have sparked shareholder tension and could drive short‑term volatility.
Technical signals are mixed: the 20‑day SMA ($3.57) sits just above the current price, the 50‑day SMA ($3.45) aligns with it, and the MACD histogram is negative, indicating a bearish tilt, while the RSI at 45 suggests no clear overbought/oversold condition. Volatility is elevated at **71%** over the past month and beta exceeds **1.6**, pointing to heightened market sensitivity. Volume is trending upward, supporting liquidity, but the combination of high leverage, activist pressure, and bearish technical cues warrants a cautious stance despite the valuation upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Activist shareholder pressure and board stalemate
  • Bearish MACD histogram and proximity to support level
  • High volatility and beta indicating price swings

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation upside versus DCF fair value
  • Forward earnings visibility and low forward P/E
  • Potential revenue synergies from the KUBRA acquisition

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued price relative to intrinsic value
  • Strong gross margins and improving cash flow trends
  • Strategic positioning in the growing payments‑infrastructure market

Key Metrics & Analysis

Financial Health

Revenue Growth4.50%
Profit Margin-82.73%
P/E Ratio3.2
ROE-43.94%
ROA-0.39%
Debt/Equity84.22
P/B Ratio0.6
Op. Cash Flow$105.4M
Free Cash Flow$45.7M
Industry P/E33.3

Technical Analysis

TrendNeutral
RSI45.6
Support$3.17
Resistance$4.22
MA 20$3.57
MA 50$3.45
MA 200$3.87
MACDBearish
VolumeIncreasing
Fear & Greed Index87.64

Valuation

Fair Value$4.16
Target Price$5.93
Upside/Downside71.84%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.61
Volatility71.06%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.